|
1
|
Notifying Member
|
Hong Kong, China
|
|
2
|
Title of new
legislation/procedure
|
Dangerous Drugs
Ordinance (Amendment of First Schedule) Order 2025 (DDO Order)
|
|
3
|
Date of Publication
|
12 February 2025
|
|
4
|
Date of entry into force
|
14 February 2025
|
|
5
|
Website link/Official
publication of the new regulation/procedure
|
https://www.info.gov.hk/gia/general/202502/12/P2025021100159.htm
|
|
6
|
Have you attached a copy of the
regulation (PDF) to the Secretariat
|
[X] Yes. (Please attach a copy of the regulation to the notification.)
321-DDO Order.pdf
[] No.
|
|
7
|
Type of notification
|
[] (a) New
licensing regulation/procedure[2];
(please answer question 8 to 14)
[X] (b) Changes
to a regulation/procedure which has been previously notified in document: _G/LIC/N/2/HKG/14, _G/LIC/N/2/HKG/19, _G/LIC/N/2/HKG/22 and _G/LIC/N/3/HKG/28 (please
answer question 15 and 16)
|
|
8
|
List of products subject to
licensing
|
|
|
9
|
Nature of licensing
|
Automatic: []
Non-Automatic: []
|
|
10
|
Administrative purpose/measure
being implemented
|
(a)
|
|
Protect public morals;
|
|
(b)
|
|
Protect human, animal or plant life and health;
protect environment;
|
|
(c)
|
|
Collect trade statistics or market surveillance;
|
|
(d)
|
|
Protection of patents, trademarks and copyrights, and
the prevention of deceptive practices;
|
|
(e)
|
|
Pursue obligations under the UN Charter and other
international treaties (i.e. CITES, Basel
Convention, Rotterdam Convention, UNSC Resolutions etc.)
|
|
(f)
|
|
Quota (including TRQ) administration;
|
|
(g)
|
|
Regulate imports of arms, ammunition or fissionable
materials and safeguard national security;
|
|
(h)
|
|
Other: ______________ (please specify)
|
|
11
|
Administrative body(ies) for
submission of applications
|
|
|
12
|
Contact point for information
on eligibility
|
|
|
13
|
Expected duration of licensing
procedure
|
|
|
14
|
A
summary of the notification in one of the WTO official languages
|
|
|
15
|
In
the case of 7(b), please indicate the type of new change(s)
|
|
(a)
|
|
Termination
|
|
(b)
|
|
Suspension
|
|
(c)
|
|
Modification of specific
details in existing
procedures:
|
|
|
Product coverage;
|
|
|
Administrative
purpose;
|
|
|
Automatic or
Non-automatic;
|
|
|
Duration of
licensing;
|
|
|
Change the nature of
quantity/value restriction;
|
|
|
Eligibility of
applicants;
|
|
|
Contact information
on eligibility;
|
|
|
Administrative
body(ies) for submission of application;
|
|
|
Documentation
requirements (including application form);
|
|
|
Period for
Application;
|
|
|
Administrative
body(ies) to issue licence;
|
|
|
Processing time for
issuing licence;
|
|
|
Licence
fee/administrative charge;
|
|
|
Deposit/advance
payment and relevant conditions;
|
|
|
Appeal
regulations/procedures;
|
|
|
Validity of licence;
|
|
|
Other conditions of
licence (extension, transferability, penalty of non-use etc.);
|
|
|
Foreign exchange
requirements;
|
|
|
Other:
|
|
|
|
|
|
|
16
|
Please
elaborate the changes in detail (in one of the WTO official languages)
|
Under the Dangerous Drugs Ordinance (DDO)
(Cap. 134), substances included in Part I of the First Schedule are dangerous
drugs and are subject to the control of a licensing scheme administered by
the Department of Health (DH). The manufacture, import, export and
supply of these substances will require respective licences issued by
DH. With effect from 14 February 2025, the DDO Order has added six
substances, namely, butonitazene, bromazolam (both under Hong Kong Harmonized
System (HKHS) code ex 2933 9900), etomidate, metomidate, propoxate, and
isopropoxate (all under HKHS code ex 2933 2900), to the First Schedule
to the DDO.
The amendments aim to deter any potential trafficking
and abuse of these dangerous drugs and will help fortify Hong Kong's defence
against drugs.
|